EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours

Jan Roška, João Lobo iD, Danica Ivovič, Lenka Wachsmannová, Thomas Mueller iD, Rui Henrique iD, Carmen Jerónimo iD, Miroslav Chovanec iD, Dana Jurkovičová iD

International Journal of Molecular Sciences · 27.01.2023 · 24 (3) · 2495

DOI: 10.3390/ijms24032495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.01.2023. Verfasst von Jan Roška und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slov…. Hauptthemen laut MEDLINE: MicroRNAs, Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VEGA Grant Agency of the Slovak Republic, Slovak Research and Development Agency, Ministry of Education, Science Research and Sport of the Slovak Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Testicular germ cell tumours (TGCTs) are the most common solid malignancy among young men, and their incidence is still increasing. Despite good curability with cisplatin (CDDP)-based chemotherapy, about 10% of TGCTs are non-responsive and show a chemoresistant phenotype. To further increase TGCT curability, better prediction of risk of relapse and early detection of refractory cases is needed. Therefore, to diagnose this malignancy more precisely, stratify patients more accurately and improve decision-making on treatment modality, new biomarkers are still required. Numerous studies showed association of differential expressions of microRNAs (miRNAs) with cancer. Using microarray analysis followed by RT-qPCR validation, we identified specific miRNA expression patterns that discriminate chemoresistant phenotypes in TGCTs. Comparing CDDP-resistant vs. -sensitive TGCT cell lines, we identified miR-218-5p, miR-31-5p, miR-125b-5p, miR-27b-3p, miR-199a-5p, miR-214-3p, let-7a and miR-517a-3p as significantly up-regulated and miR-374b-5p, miR-378a-3p, miR-20b-5p and miR-30e-3p as significantly down-regulated. In patient tumour samples, we observed the highest median values of relative expression of miR-218-5p, miR-31-5p, miR-375-5p and miR-517a-3p, but also miR-20b-5p and miR-378a-3p, in metastatic tumour samples when compared with primary tumour or control samples. In TGCT patient plasma samples, we detected increased expression of miR-218-5p, miR-31-5p, miR-517a-3p and miR-375-5p when compared to healthy individuals. We propose that miR-218-5p, miR-31-5p, miR-375-5p, miR-517-3p, miR-20b-5p and miR-378a-3p represent a new panel of biomarkers for better prediction of chemoresistance and more aggressive phenotypes potentially underlying metastatic spread in non-seminomatous TGCTs. In addition, we provide predictions of the targets and functional and regulatory networks of selected miRNAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsTesticular NeoplasmsNeoplasms, Germ Cell and EmbryonalHumansMaleCisplatinEarly Detection of CancerBiomarkersMicroarray AnalysisData AnalysisGene Expression ProfilingBiomarkers, Tumor

Stichwörter der Autor:innen

biomarkercisplatinmiRNAmiRNA microarraytesticular germ cell tumour

Substanzen

CisplatinMicroRNAsBiomarkersBiomarkers, TumorMIRN214 microRNA, humanMIRN218 microRNA, human

Autor:innen und Institutionen

  • Department of Genetics, Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Dúbravská cesta 9, 845 05 Bratislava, Slovakia.
  • Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Rua…
  • Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
  • Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences-University of Porto (ICBAS-UP), Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
  • University Clinic for Internal Medicine IV, Hematology/Oncology, Medical Faculty of Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.

ORCID-Profile: João Lobo, Thomas Mueller, Rui Henrique, Carmen Jerónimo, Miroslav Chovanec, Dana Jurkovičová

Förderung

  • VEGA Grant Agency of the Slovak Republic
  • Slovak Research and Development Agency
  • Ministry of Education, Science Research and Sport of the Slovak Republic
  • European Regional Development Fund, Integrated Infrastructure Operational Program
  • Research Center of Portuguese Institute of Porto
  • Ministry of Health of the Slovak Republic

Zitieren

APA

Roška, J., Lobo, J., Ivovič, D., Wachsmannová, L., Mueller, T., Henrique, R., Jerónimo, C., Chovanec, M., & Jurkovičová, D. (2023). Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. International Journal of Molecular Sciences, 24(3), 2495. https://doi.org/10.3390/ijms24032495

Vancouver

Roška J, Lobo J, Ivovič D, Wachsmannová L, Mueller T, Henrique R, et al. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. International Journal of Molecular Sciences. 2023;24(3):2495. doi:10.3390/ijms24032495

BibTeX
@article{Roka2023,
  author = {Roška, Jan and Lobo, João and Ivovič, Danica and Wachsmannová, Lenka and Mueller, Thomas and Henrique, Rui and Jerónimo, Carmen and Chovanec, Miroslav and Jurkovičová, Dana},
  title = {Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {3},
  pages = {2495},
  doi = {10.3390/ijms24032495}
}
Kostenlos starten →